Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
ConditionHearing Loss, Sensorineural
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorPamukkale University
About this trial
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Eligibility criteria
Qualifiers
Patients with sensorineural hearing loss
Patients who will have cochlear implant surgery with CI422 electrode
Disqualifiers
Patients with cochlear abnormality
Patients with auditory neuropathy
Trial design
Treatments tested in this trial
- intracochlear platelet rich fibrin administration
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
1Pamukkale University20070, Denizli Turkey (Türkiye)
Sponsors and collaborators
Pamukkale University
Lead sponsor
Source ClinicalTrials.gov